Insulin Lispro
- Generic Name
- Insulin Lispro
- Brand Names
- Admelog, Humalog, Humalog Mix, Humalog kwikpen, Liprolog, Lyumjev, Insulin lispro Sanofi, Lyumjev (previously Liumjev)
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 133107-64-9
- Unique Ingredient Identifier
- GFX7QIS1II
- Background
Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is release...
- Indication
本品尤其适用于下列情况：
1.经常发生低血糖的1型糖尿病者，使用本品可减少低血糖的发生率；
2.生活不规律，外出活动较多的用胰岛素治疗的糖尿病患者，本品快速、短效的特点有助于及时调整胰岛素的用量。
- Associated Conditions
- Diabetes Mellitus, Diabetic Ketoacidosis, Gestational Diabetes Mellitus (GDM)
- Associated Therapies
- -
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
- Conditions
- Interventions
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 112
- Registration Number
- NCT06370715
- Locations
- 🇮🇳
Rajasthan University of Health Sciences, Jaipur, Rajasthan, India
🇮🇳S. P. Medical College & A G Hospital, Bikaner, Rajasthan, India
🇮🇳Osmania Medical College & Hospital, Hyderabad, Telangana, India
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 70
- Registration Number
- NCT06280703
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, Germany
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 30
- Registration Number
- NCT06046417
- Locations
- 🇨🇦
Research Institute of the McGill University Health Center, Montreal, Quebec, Canada
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
- Conditions
- Interventions
- First Posted Date
- 2023-06-08
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 36
- Registration Number
- NCT05893797
- Locations
- 🇫🇷
Centre Hospitalier Sud Francilien-Pharmacie, Corbeil-Essonnes, France
🇫🇷CHU de Caen Hôpital Cote de Nacre, Caen, Cedex 9, France
🇫🇷Chu de Grenoble, Grenoble Cédex 9, France
A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)
- Conditions
- Interventions
- First Posted Date
- 2021-03-25
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Adocia
- Target Recruit Count
- 80
- Registration Number
- NCT04816890
- Locations
- 🇩🇪
Profil Mainz GmbH & Co, Mainz, Germany
🇩🇪Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 32
- Registration Number
- NCT04276207
- Locations
- 🇩🇪
Profil Mainz GmbH & Co. KG, Mainz, Rheinland-Pfalz, Germany
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
- First Posted Date
- 2019-11-13
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 20
- Registration Number
- NCT04161976
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, Germany
The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
- Conditions
- Interventions
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Medical University of Warsaw
- Target Recruit Count
- 70
- Registration Number
- NCT04124302
A Study of LY900014 in Healthy Chinese Participants
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 15
- Registration Number
- NCT04049123
- Locations
- 🇨🇳
West China Hospital Sichuan University, Cheng Du, Cn-51, China
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
- Conditions
- Interventions
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Medical University of Warsaw
- Target Recruit Count
- 72
- Registration Number
- NCT04019821
- Locations
- 🇵🇱
Department of Pediatric Diabetology and Pediatrics, Pediatric Teaching Clinical Hospital, Warsaw, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.